The FDA approved TMS NeuroStar device to treat Obsessive-Compulsion Disorder in May 2022.
Thank you to those who have and continue to serve, we are thinking of you all.
You Might Also Enjoy...
The FDA approved TMS NeuroStar device to treat Obsessive-Compulsion Disorder in May 2022.
Read about how we use magnetic resonance therapy (MeRT) as a customized use of Transcranial Magnetic Stimulation (TMS).
While TMS is an FDA approved treatment to relieve symptoms of treatment resistant depression, it can be used for many off-label purposes as well.
Historic events have unfolded in the past few year and studies have shown that there is a link between the current state of the news and individual's mental health.
The World Health Organization (WHO) released a scientific brief that stated that there was a dramatic 25% increase in the global prevalence of depression and anxiety during the first year of the COVID-19 pandemic.
Happy Brain Awareness Week! Read more about the effect of different brain chemical messengers and their effect on mental health and every day functioning.